You are viewing a limited version of this profile. To access i3's full capabilities.
ArkeaBio
Save
Company logo (jpg or png)
Parent company

Short description

Developer of vaccine to reduce ruminant methane emissions

Founded in 2022
Founded in

Company type Private Public ()
Company type

Industry Group agriculture & food

Sector animals

TRL Range 7-8
TRL 1 Basic research
TRL 2 Technology formulation
TRL 3 Applied research
TRL 4 Small scale prototype
TRL 5 Large scale prototype
TRL 6 Prototype system
TRL 7 Demonstration system
TRL 8 First of a kind commercial system
TRL 9 Full commercial application
TRL Range

Ticker

Headquarters Boston, MA Boston, United States
Address
City
State
Zip
Country

Parent Companies

Updated by Cleantech Group on 05/09/2024

Traction
  • 0 M&A items
tags
Industry Group Sector
Tags
Similar companies
Customers
Save
Date Company
Partnerships
Save
Date Partner Type
05/07/2024
Breakthrough Energy Breakthrough Energy
Test
View source    
Confirmed by Breakthrough Energy
Incubation/Acceleration
Investment Rounds
Save

IPO INFORMATION

Date

IPO status

IPO Type

Amount

Initial shares

Ticker symbol

Exchange listed

Prospectus URL

Prospectus

Source URL

Source

Description

Date Investors Type Amount
05/09/2024 Breakthrough Energy Ventures Breakthrough Energy Ventures , Grantham Foundation Grantham Foundation , AgriZeroNZ AgriZeroNZ , Rabo Ventures Rabo Ventures , Overview Overview , The51 Food & AgTech Fund The51 Food & AgTech Fund (6)
Post-money valuation of
The company intends to use the funds to advance the research, development, and deployment of its vaccine, including large-scale field trials and engagement along the supply chain.
Series A $26,500,000
Click to add IPO information
Products
Save
Product image Name Product status Revenue model Cost metrics
You are viewing a limited version of this profile. To access i3's full capabilities.
Back to top

Preload svg text font